Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Primidone in Duchenne muscular dystrophy
ChiCTR2200063970Phase 2Not yet recruiting
- Sponsor
- Yichang First People's Hospital
- Start
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of primidone in Duchenne muscular dystrophy (DMD) (3 arms), sponsored by Yichang First People's Hospital. Primary endpoints: Creatine kinase and Plasma concentration of primidone. Planned start Dec 2022; status: not yet recruiting.
02
Drugs
primidone
03
Conditions
Duchenne muscular dystrophy (DMD)
Beyond the preview
Go deeper on ChiCTR2200063970.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200063970.